Taro Pharmaceuticals U.S.A., Inc.401(k)
TARO PHARMACEUTICALS U.S.A., INC 401(K) PLAN · HAWTHORNE, NY · plan year 2023
Peer grade: B+ · admin costs + employer contributions vs same-size plans · how grading works
Taro Pharmaceuticals U.S.A., Inc. reported $45,464 in plan administrative expenses for 2023: 0.13% of average plan assets, below the peer median. Employer contributions averaged $2,957 per active participant. This ratio covers administrative expenses reported on the plan's Schedule H only; fund-level expense ratios are not included in public structured data — see methodology.
Across the 2 years on file its reported administrative ratio has held roughly steady near 0.129%. The plan sits in the $10M–$50M size bracket, benchmarked here against 26,779 comparable plans and shown alongside other wholesale trade employers. By assets it is the 1,675th-largest of 5,648 plans among New York employers on file, and the 1,091st of 4,246 in wholesale trade. In 2023, employees put in $2.78 for every $1.00 the employer contributed; active participation has grown from 113 to 188 since 2022.
Taro Pharmaceuticals U.S.A., Inc.'s 2023 employer contribution ran above the $2,440 median for plans its size. Filings report dollars actually contributed, not the match formula; the formula itself (for example, 50% of the first 6% of pay) lives in the plan's summary plan description from HR.
Annual cost at the plan's reported 2023 administrative ratio, against the median plan its size; fund expense ratios are extra. Compare any plan.
Compensation shown is direct payments from plan assets reported on Schedule C. Providers paid through fund revenue-sharing appear as indirect.
Why are you looking at this plan?
Source: U.S. Department of Labor, Form 5500 series, EIN 112072868 · Verify on EFAST2 · Amounts are as reported by the plan sponsor for the plan year shown.